He was previously associated with renowned companies such as Granules India Ltd, Dr. Reddy’s Laboratories ltd & Aptar Group
The Board of Directors of Supriya Lifescience Limited has approved the appointment of Krishna Raghunathan as the Chief Financial Officer (CFO) of the company with effect from January 23, 2023.
Krishna Raghunathan is a dynamic professional with 23+ years of rich experience in financial management and the ability to apply this knowledge to a variety of different business contexts. In his last role, Raghunathan worked for around 5 years as Vice President – Finance, Treasury and Investor Relations with a listed pharmaceuticals company.
Raghunathan has a demonstrated history of working in diverse industries including pharmaceuticals, packaging, and information technology. Raghunathan is a seasoned pharmaceutical specialist with more than two decades of experience in companies like Dr. Reddy’s Laboratories Limited and Granules India Limited. His appointment is in line with the company's strategy to achieve accelerated growth in the years to come.
Raghunathan has a diverse and extensive background in finance, with experience in a range of industries including pharmaceuticals, packaging, and information technology. He was previously associated with renowned companies such as Granules India Ltd, Dr. Reddy’s Laboratories ltd & Aptar Group.
On the qualification front, he is a Chartered Accountant (CA) from ICAI and he has bachelor degree of Science in Zoology from Madras University, Chennai.
Ashish Nayak has resigned from the position of Chief Financial Officer of the company and the Board has accepted his resignation with effect from close of business hours on January 23, 2023, however he will be relieved from the company on January 31, 2023, for smooth transition to his successor.
Subscribe To Our Newsletter & Stay Updated